OSRH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
315.7K
-34.8%
484.1K
+27.0%
381.3K
-39.3%
627.7K
-44.7%
1.1M
Cost of Revenue
229.1K
-29.3%
323.8K
+28.7%
251.6K
-31.3%
366.0K
-66.8%
1.1M
Gross Profit
86.6K
-46.0%
160.3K
+23.6%
129.7K
-50.4%
261.7K
+698.4%
32.8K
Operating Expenses
3.1M
-18.5%
3.8M
-41.3%
6.5M
+60.3%
4.1M
-22.7%
5.3M
R&D
0
0
0
0
0
SG&A
3.1M
-18.5%
3.8M
-41.3%
6.5M
+60.3%
4.1M
-22.7%
5.3M
Operating Income
-3032915
+17.3%
-3667183.53
+42.6%
-6385534
-67.9%
-3803466
+27.3%
-5229178
EBITDA
-5441167.17
-338.3%
-1241424.3599999999
+69.7%
-4090968
-188.8%
-1416720
+81.1%
-7501791.79
Net Income
-1004038
+71.0%
-3467174.08
+52.1%
-7245655
-126.8%
-3194874
+38.9%
-5225198
EPS (Basic)
$-0.02
+77.8%
$-0.09
+43.8%
$-0.16
-60.0%
$-0.10
-600.0%
$0.02
EPS (Diluted)
$-0.02
+77.8%
$-0.09
+18.2%
$-0.11
-10.0%
$-0.10
-600.0%
$0.02
Shares (Diluted)
32.9M
-4.0%
34.3M
-20.1%
42.9M
+101.8%
21.3M
+40.3%
15.2M
OSR Health (OSRH) โ€” Financials